United StatesLevothyroxine Sodium Tablets, USP 300 mcg (0.3 mg) in 90-tablet prescription bottles (NDC 16729-458-15), lot D2401522, exp. 06/2026, manufactured for Accord Healthcare and made by Intas Pharmaceuticals, are being recalled nationwide in the U.S.; 6,432 bottles are included. The product was recalled because it is subpotent.
What's being recalled
Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: lntas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-458-15.
Recalling firm: Accord Healthcare, Inc., Raleigh, NC, United States.
How to identify it
Lot # D2401522, Exp Date: 06/2026.
The hazard
Subpotent Drug
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
US Nationwide.
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)